Showing results (1-10 of 44) with videos related to
Sort By:
Pageof 5
Ultrasound in Medicine & Biology|January 1, 1997
Contrast ultrasonography for 2-D opacification of heart cavities, peripheral vessels, kidney and muscleA L Strauss, K D BellerUltraschall in Der Medizin (Stuttgart, Germany : 1980)|December 1, 1996
[Duplex ultrasound with echo contrast media]A L Strauss, K D BellerUltrasound in Medicine & Biology|July 22, 1999
Persistent opacification of the left ventricle and myocardium with a new echo contrast agentA L Strauss, K D BellerUltrasound in Medicine & Biology|January 1, 1996
Pharmacokinetic studies of different echo-contrast agents in the cerebral circulation of dogsG Seidel, K D Beller, M KapsBasic Research in Cardiology|January 1, 1996
Comparison of a new intravenous echo contrast agent (BY 963) with Albunex for opacification of left ventricular cavityR Leischik, K D Beller, R ErbelArzneimittel-Forschung|November 11, 1999
[The effect of carvedilol on contrast echocardiography in comparison to metoprolol in conscious dogs]K D Beller, F Diedrich, G SponerJournal of Neuroimaging : Official Journal of the American Society of Neuroimaging|July 17, 1998
Administration of modified spherosome suspension (BY963) leads to an increase of acoustic impedance in dog brain tissueG Seidel, K D Beller, M KapsThe American Journal of Cardiology|August 15, 1989
Involvement of brain 5-HT1A receptors in the hypotensive response to urapidilN Kolassa, K D Beller, K H SandersThe American Journal of Cardiology|February 2, 1989
Evidence for the interaction of urapidil with 5-HT1A receptors in the brain leading to a decrease in blood pressureN Kolassa, K D Beller, K H SandersJournal of Cardiovascular Pharmacology|January 1, 1990
Involvement of 5-HT1A receptors in blood pressure reduction by 8-OH-DPAT and urapidil in catsK H Sanders, K D Beller, N KolassaPageof 5